In this article (Clin Cancer Res 2011;17:6944–51), which was published in the November 1, 2011, issue of Clinical Cancer Research (1), in Table 3, under CYP2D6*4, the number of Wt/Wt patients was mislabeled. This should be 1,116 as opposed to 116. All analyses and reported results were based upon the correct number of wild-type alleles for CYP2D6 *4 (1,116). Therefore, the results remain unchanged. The authors regret this error.

1.
Goetz
MP
,
Schaid
DJ
,
Wickerham
DL
,
Safgren
S
,
Mushiroda
T
,
Kubo
M
, et al
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials
.
Clin Cancer Res
2011
;
17
:
6944
51
.